Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy (NCT01585987) | Bristol-Myers Squibb | 2012-07-01 |
Track Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction automatically
Every clearance here is in the API, with alerts when new ones post.